Annelieke E C A B Willemsen

4PUBLICATIONS
7CO-AUTHORS
Predictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Environmental epidemiologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 24, 2025
Palbociclib Is Safe for Breast Cancer Patients With Mild Hepatic Impairment: A Multicenter Retrospective Study Using Real-World Data.

Alieke K Bos, Annelieke E C A B Willemsen, Loes E Visser

|May 28, 2019
Molecular tumour boards and molecular diagnostics for patients with cancer in the Netherlands: experiences, challenges, and aspirations.

Annelieke E C A B Willemsen, Sarah Krausz, Marjolijn J L Ligtenberg

|Sep 28, 2018
Everolimus Exposure and Early Metabolic Response as Predictors of Treatment Outcomes in Breast Cancer Patients Treated with Everolimus and Exemestane.

Annelieke E C A B Willemsen, Lioe-Fee de Geus-Oei, Maaike de Boer

|Oct 11, 2015
mTOR inhibitor-induced interstitial lung disease in cancer patients: Comprehensive review and a practical management algorithm.

Annelieke E C A B Willemsen, Jan C Grutters, Winald R Gerritsen

Pageof 1

Frequent Collaborators

1 joint publications

Alieke K Bos

1 joint publications

Loes E Visser

1 joint publications

Lennart J Stoker

1 joint publications

Jurjen S Kingma